372 results
EBM Focus: Another mAb in the Mix for the Management of Severe Asthma
Adding biologic treatments to standard care helps many patients with severe, uncontrolled asthma to breathe easier. This EBM Focus explains how depemokimab (a monoclonal antibody, or mAb, not yet FDA approved) differs from other biologic agents.
GLP-1 Agonists for Weight Loss: Navigating a Nontraditional Drug Market filled with Compounded Drugs and Counterfeits
Helping patients navigate the weight loss drug landscape to access GLP-1 agonists safely.